Well-controlled autoimmune hepatitis treatment withdrawal may be safely accomplished without liver-biopsy guidance

BACKGROUND: Autoimmune hepatitis may flare up after treatment withdrawal, especially in those who had not achieved histological remission but had normal liver enzymes. The European Association for the Study of the Liver (EASL) and the American Association for the Study of Liver Disease (AASLD) Guide...

Descripción completa

Detalles Bibliográficos
Autores principales: Guirguis, John, Alonso, Yilien, Lopez, Rocio, Carey, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225821/
https://www.ncbi.nlm.nih.gov/pubmed/30430017
http://dx.doi.org/10.1093/gastro/goy020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225821/
https://www.ncbi.nlm.nih.gov/pubmed/30430017
http://dx.doi.org/10.1093/gastro/goy020

Ejemplares similares